Save time and jump to the most important pieces.
Date | Price Target | Rating | Analyst |
---|---|---|---|
5/8/2025 | $84.00 | Equal Weight → Overweight | Barclays |
2/20/2025 | $77.00 | Buy → Sell | CFRA |
1/7/2025 | Hold → Buy | Argus | |
11/12/2024 | $111.00 → $110.00 | Equal-Weight → Overweight | Morgan Stanley |
11/8/2024 | $107.00 | Neutral → Buy | BofA Securities |
11/7/2024 | $109.00 | Hold → Buy | Vertical Research |
9/11/2024 | $116.00 → $117.00 | Outperform | Oppenheimer |
9/3/2024 | $109.00 → $120.00 | Neutral → Outperform | Mizuho |
IFF (NYSE:IFF) today announced that it has completed the divestiture of its nitrocellulose business, including Walsrode Industrial Park in lower Saxony, Germany, to Czechoslovak Group (CSG). The business manufactures nitrocellulose strictly for industrial purposes, serving customers primarily in coatings and printing inks, and had been part of IFF's Pharma Solutions business unit. "The divestiture of our nitrocellulose business builds upon our deleveraging journey and enables us to focus on our core businesses," said Erik Fyrwald, IFF CEO. "I'd like to thank our nitrocellulose colleagues for their dedication and wish them continued success as part of CSG." Welcome to IFF At IFF (NYSE:IFF)
IFF (NYSE:IFF) reported financial results for the first quarter ended March 31, 2025. First Quarter 2025 Consolidated Summary: Reported (GAAP) Adjusted (Non-GAAP)1 Sales Loss Before Taxes* EPS Operating EBITDA Operating EBITDA Margin EPS ex Amortization $2.8 B $(994) M $(3.98) $578 M 20.3% $1.20 * Impacted by an impairment of goodwill of $1.15B in Food Ingredients Management Commentary "IFF delivered solid first quarter results, driven by disciplined execution and broad-based growth across most of our business," said IFF CEO Erik Fyrwald. "Our growth, combined with ongoing product
IFF (NYSE:IFF) announced today the commencement of tender offers to purchase for cash certain of its outstanding series of notes listed in the tables below (collectively, the "Notes") for an aggregate purchase price, excluding accrued and unpaid interest, of up to $1.8 billion. Pool 1 Tender Offers Pool 1 Maximum Amount: $1.0 billion(1(a)) Title of Security CUSIP/ISIN Principal Amount Outstanding(in millions) Acceptance Priority Level(2) Series Tender Cap(3) U.S. Treasury Reference Security Bloomberg Reference Page Fixed Spread(4) Early Tender Payment (4)(5) 1.230% Senior Notes due 2025 459506AN1 U45950AE9 $1,000 1 $500 million 5.000%
4 - INTERNATIONAL FLAVORS & FRAGRANCES INC (0000051253) (Issuer)
4 - INTERNATIONAL FLAVORS & FRAGRANCES INC (0000051253) (Issuer)
4 - INTERNATIONAL FLAVORS & FRAGRANCES INC (0000051253) (Issuer)
SC 13G/A - INTERNATIONAL FLAVORS & FRAGRANCES INC (0000051253) (Subject)
SC 13G/A - INTERNATIONAL FLAVORS & FRAGRANCES INC (0000051253) (Subject)
SC 13G - INTERNATIONAL FLAVORS & FRAGRANCES INC (0000051253) (Subject)
8-K - INTERNATIONAL FLAVORS & FRAGRANCES INC (0000051253) (Filer)
10-Q - INTERNATIONAL FLAVORS & FRAGRANCES INC (0000051253) (Filer)
8-K - INTERNATIONAL FLAVORS & FRAGRANCES INC (0000051253) (Filer)
IFF (NYSE:IFF) reported financial results for the first quarter ended March 31, 2025. First Quarter 2025 Consolidated Summary: Reported (GAAP) Adjusted (Non-GAAP)1 Sales Loss Before Taxes* EPS Operating EBITDA Operating EBITDA Margin EPS ex Amortization $2.8 B $(994) M $(3.98) $578 M 20.3% $1.20 * Impacted by an impairment of goodwill of $1.15B in Food Ingredients Management Commentary "IFF delivered solid first quarter results, driven by disciplined execution and broad-based growth across most of our business," said IFF CEO Erik Fyrwald. "Our growth, combined with ongoing product
IFF (NYSE:IFF) announced that its Board of Directors has declared a regular quarterly cash dividend of $0.40 per share of its common stock, payable on July 11, 2025 to shareholders of record as of June 20, 2025. Welcome to IFF At IFF (NYSE:IFF), we make joy through science, creativity and heart. As the global leader in flavors, fragrances, food ingredients, health and biosciences, we deliver groundbreaking, sustainable innovations that elevate everyday products—advancing wellness, delighting the senses and enhancing the human experience. Learn more at iff.com, LinkedIn, Instagram and Facebook. © 2025 by International Flavors & Fragrances Inc. IFF is a Registered Trademark. All Rights Res
IFF (NYSE:IFF) today announced that it will release its first quarter 2025 earnings results following the market close on Tuesday, May 6, 2025. The management team will host a live webcast on Wednesday, May 7, 2025, at 9:00 a.m. ET to discuss results and outlook with the investor community. Investors may access the live webcast and accompanying slide presentation on the Company's website at ir.iff.com. For those unable to listen to the live webcast, a recorded version will be made available for replay. Welcome to IFF At IFF (NYSE:IFF), we make joy through science, creativity and heart. As the global leader in flavors, fragrances, food ingredients, health and biosciences, we deliver groun
4 - INTERNATIONAL FLAVORS & FRAGRANCES INC (0000051253) (Issuer)
4 - INTERNATIONAL FLAVORS & FRAGRANCES INC (0000051253) (Issuer)
Alexandra Carlin and Alex Lee join the Paris-based fine fragrance team, bringing fresh artistic perspectives PARIS, Nov. 4, 2024 /PRNewswire/ -- IFF (NYSE:IFF) proudly welcomes Alexandra Carlin as Senior Fine Fragrance Perfumer and Alex Lee as Fine Fragrance Perfumer to its Paris-based team. These strategic additions aim to enhance the Company's creative prowess in the world of perfumery. "We're excited for the talent and creative energy that Alexandra and Alex will bring to IFF Scent," said Sabrya Meflah, president, Fine Fragrance, IFF. "Alexandra's ability to translate deep
NEW YORK, Sept. 26, 2024 /PRNewswire/ -- IFF (NYSE:IFF) Pharma Solutions is proud to announce its more than 75-year legacy as an excipient manufacturer with new product launches and technologies for the pharmaceutical and biotech industries. Celebrating this pivotal milestone, IFF will spotlight its latest solutions for nitrosamine mitigation at CPHI 2024, Milan, Oct. 8-10, booth 6B10. The range includes a new portfolio of low nitrite excipients and ultrapure alginate biopolymers for next-generation therapeutic development. "We are unveiling groundbreaking technologies that re
IFF (NYSE:IFF) today announced the appointment of Margarita Paláu-Hernández to its Board of Directors, effective June 3, 2024. Paláu-Hernández joins as a mutually agreed independent Director in connection with IFF's previously disclosed cooperation agreement with Icahn Capital LP and its affiliates. Following the appointment of Paláu-Hernández, the Board will be comprised of 11 members, ten of which are independent. "We are pleased to welcome Maggie to the IFF Board," said Roger Ferguson, lead director of IFF. "Her legal expertise, consumer insights, and her experience in emerging markets will be invaluable to IFF as we continue to execute on our growth and transformation plan to drive in
Barclays upgraded Intl Flavors from Equal Weight to Overweight and set a new price target of $84.00
CFRA downgraded Intl Flavors from Buy to Sell and set a new price target of $77.00
Argus upgraded Intl Flavors from Hold to Buy